Augmenta vaccine technology wins US patent
News | 21 January 2013
Select a Pharmaceutical sector, ------------------------, Fine & Speciality Chemicals, Manufacturing, Process & Production, OTC, ------------------------, Drug Delivery, Drug Discovery & Development, ------------------------, Clinical Trials, Contract ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
